To Include or Occlude: Rational Engineering of HCV Vaccines for Humoral Immunity

Direct-acting antiviral agents have proven highly effective at treating existing hepatitis C infections but despite their availability most countries will not reach the World Health Organization targets for elimination of HCV by 2030. A prophylactic vaccine remains a high priority. Whilst early vacc...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlotthauer, Felicia, McGregor, Joey, Drummer, Heidi E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146105/
https://www.ncbi.nlm.nih.gov/pubmed/33946211
http://dx.doi.org/10.3390/v13050805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146105/
https://www.ncbi.nlm.nih.gov/pubmed/33946211
http://dx.doi.org/10.3390/v13050805

Ejemplares similares